Status:

UNKNOWN

The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency

Lead Sponsor:

Shanghai University of Traditional Chinese Medicine

Conditions:

Heart Failure With Preserved Ejection Fraction

Eligibility:

All Genders

30-80 years

Phase:

PHASE2

Brief Summary

This study was designed as a randomized, double blinded and placebo-controlled clinical trial. The aim of the study is to evaluate the efficacy and safety of Zhigancao Tang granule in patients with HF...

Detailed Description

Heart failure with preserved ejection fraction (HFPEF) is a clinical syndrome characterized by diastolic dysfunction.The incidence of HFpEF is increasing in recent years. Standard treatment of heart f...

Eligibility Criteria

Inclusion

  • Comply with the diagnostic criteria of Western medicine for HFpEF and the diagnostic criteria for TCM syndromes of Qi-Yin deficiency;
  • Cardiac function classification by NYHA: grade I to III;
  • Age between 30 and 80 years old;
  • Those who volunteer to participate in clinical trial observation, sign informed consent and indicate date;
  • During the observation period, those who do not take other drugs other than those specified and can insist on completing the treatment and observation.

Exclusion

  • Valvular heart disease, restrictive cardiomyopathy, pericardial disease;
  • Decompensated heart failure is unstable after treatment;
  • Combined with atrial fibrillation;
  • Patients with severe lung, liver, endocrine system and kidney dysfunction;
  • Patients with cancer and other common malignant diseases reducing life expectancy;
  • Pregnant or lactating women;
  • Allergic constitution or allergic history to common drugs;
  • Patients with mental illness or poor compliance of traditional Chinese medicine treatment.

Key Trial Info

Start Date :

March 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2022

Estimated Enrollment :

122 Patients enrolled

Trial Details

Trial ID

NCT04317339

Start Date

March 20 2020

End Date

March 31 2022

Last Update

March 23 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Longhua Hospital

Shanghai, Shanghai Municipality, China, 200032